| PACKAGING TYPE: | 5ml C-box |
| COMPOSITION: | Dorzolamide(2%w/v) & Timolol Maleate(0.5%w/v) Eye Drop |
| FORMULATION: | Drop |
| Description: | DORALIS-T Eye Drop is a combination ophthalmic solution used in the management of glaucoma and ocular hypertension. It combines Dorzolamide, a carbonic anhydrase inhibitor, and Timolol, a beta-blocker, to provide dual action in reducing intraocular pressure. This combination is particularly useful in patients who do not respond adequately to single-agent therapy, helping prevent optic nerve damage and vision loss. |
| Side Effects: | Burning or stinging sensation Eye irritation or redness Bitter taste Blurred vision (temporary) Rare systemic effects (due to beta-blocker) |
| How to Use: | Instill 1 drop in affected eye(s) Use as prescribed (usually twice daily) Avoid touching dropper tip Follow dosage instructions strictly |
| Precaution: | For ophthalmic use only Use under medical supervision Not recommended in asthma or severe heart conditions Remove contact lenses before use Store in a cool and dry place |
| Product Benefits: | Effectively reduces intraocular pressure Dual-action formula for better control Helps manage glaucoma and ocular hypertension Prevents optic nerve damage Suitable for patients requiring combination therapy |
Frequently Asked Questions
DORALIS-T Eye Drop is used to reduce increased intraocular pressure in glaucoma and ocular hypertension patients.
It contains Dorzolamide 2% w/v and Timolol Maleate 0.5% w/v.
Dorzolamide reduces aqueous humor production, while Timolol decreases fluid formation in the eye, together lowering eye pressure effectively.
Recently Viewed
BETASTINE EYE DROP
BEPOTASTINE BESILATE
EQ TO BEPOTASTINE - 1.5%W/V
BENZALKONIUM CHLORIDE 0.005 %V/V
(AS PRESERVATIVE )
STERILE AQUEOUS BASE Q.S.
₹ 320/-
BETASTINE EYE DROP
BEPOTASTINE BESILATE EQ TO BEPOTASTINE - 1.5%W/V BENZALKONIUM CHLORIDE 0.005 %V/V (AS PRESERVATIVE ) STERILE AQUEOUS BASE Q.S.
₹ 320/-
You May Like
